Nutrition Assessment in Advanced Cancer Patients

NCT06323135 | Completed

• 1 other identifier: 2019-725
• Study Type: observational
• Target: 2,115
• Locations: 1 country
• Sites: 1

Brief Summary

The goal of this retrospective observational study is to evaluate the prognostic value of nutrition assessment tool in advanced cancers. We aim to evaluate the clinical utility of nutrition assessment tool in predicting the clinical outcomes of cancer patients, which would help the clinicians to make tailored decision for this population.

Conditions

Advanced Cancer; Nutrition Aspect of Cancer; Prognostic Cancer Model

Outcome Measures

Primary Outcomes (1)

• All-cause mortality

  the all-cause mortality of cancer patients

  Nov 11, 2019 to 11 Sep, 2023

Secondary Outcomes (1)

• length of stay in hospital

  Nov 11, 2019 to 11 Sep, 2023

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

In this study, all of the cancer types were reviewed. The histological information of cancer types was confirmed by the biopsy or resected surgical specimen. The tumor stages were classified based on the guidelines of the American Joint Committee on Cancer Manual (8th edition) (32) at the initial admission. Patients with the following clinical characteristics were excluded, such as those with incomplete nutritional evaluation, incomplete blood indicator test, and loss of follow-up. Furthermore, some cancer types with small sample sizes (\<20 cases) were also excluded from the analysis because of the study's validity concerns. Ultimately, eleven types of cancers (lung cancer, colorectal cancer, esophagus cancer, gastric cancer, head and neck cancer, pancreatic cancer, liver cancer, lymphoma, urinary cancer, breast cancer, and cancer with unknown primary sites) of interest were further investigated.

You may qualify if:

• Advanced cancers

You may not qualify if:

• Aged below 18
• Incomplete blood tests
• Incomplete follow-up data

Sponsors & Collaborators

• West China Hospital: lead

Study Sites (1)

West China Hospital, Sichuan Universit

Chengdu, Sichuan, 610041, China

Location

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Director

Study Record Dates

• First Submitted: March 14, 2024
• First Posted: March 21, 2024
• Study Start: September 17, 2019
• Primary Completion: September 11, 2023
• Study Completion: September 11, 2023
• Last Updated: March 21, 2024

Record last verified: 2024-03

Data Sharing

• IPD Sharing: Will not share

Locations

CN (1)